CEVAXIN

Recent papers from CEVAXIN

1. Viral replacement or proportional change? Respiratory surveillance as RSV prevention expands in Latin AmericaThe Lancet Regional Health - Americas · 2026
2. Toward an Integrated Response to Arboviral Threats in the Americas: Perspectives from the Dengue Summit of the Global Health Conference of the Americas 2025Pathogens · 2026
3. Depression and anxiety symptoms and their psychosocial and functional correlates among people living with HIV attending two urban clinics in PanamaAIDS Care · 2026
4. A feasibility pilot study on the effects of a combined cognitive and physical intervention program in older adults in PanamaFrontiers in Dementia · 2026
5. Cryptic transmission of a SARS-CoV-2 variant detected by wastewater surveillance in PanamaFrontiers in Cellular and Infection Microbiology · 2025
6. Confronting the challenge: a regional perspective by the Latin American pediatric infectious diseases society (SLIPE) expert group on respiratory syncytial virus—tackling the burden of disease and implementing preventive solutionsFrontiers in Pediatrics · 2024
7. Immunogenicity, Reactogenicity, and Safety of AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein-based Candidate Vaccine (RSVPreF3 OA) When Co-administered With a Seasonal Quadrivalent Influenza Vaccine in Older Adults: Results of a Phase 3, Open-Label, Randomized Controlled TrialClinical Infectious Diseases · 2024
8. Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trialsThe Lancet Microbe · 2022
9. Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind studyVaccine · 2022